Expression, purification, and activity identification of Alfimeprase in Pichia pastoris

Protein Expression and Purification

Volumn 54, Issue 2, 2007, Pages 240-246

  Shi, Jing ^a   Zhang, Shou Tao ^a   Zhang, Xiao Juan ^a   Xu, Hong ^a   Guo, Ai Guang ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Alfimeprase; Fibrin plate method; Pichia pastoris; rALF

Indexed keywords

ALFIMEPRASE; METALLOPROTEINASE; RECOMBINANT PROTEIN;

ARTICLE; BIOSYNTHESIS; FIBRINOLYSIS; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; PICHIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRINOLYSIS; METALLOENDOPEPTIDASES; PICHIA; RECOMBINANT PROTEINS;

PICHIA PASTORIS;

EID: 34249011472     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.03.012     Document Type: Article

References (29)

1. Manning M.C. Sequence analysis of fibrolase, a fibrinolytic metalloproteinase from Agkistrodon contortrix contortrix. Toxicon 33 (1995) 1189-1200
2. Trikha M., Schmttmeier S., and Markland F.S. Purification and characterization of fibrolase isoforms from venom of individual southern copperhead (Agkistrodon contortrix contortrix) snakes. Toxicon 32 (1994) 1521-1531
3. Swenson S., and Markland F.S. Snake venom fibrin (ogen) olytic enzymes. Toxicon 45 (2005) 1021-1039
4. Ahmed N.K., Tennant K.D., Markland F.S., and Lacz J.P. Biochemical characteristics of fibrolase, a fibrinolytic protease from snake venom. Haemostasis 20 (1990) 147-154
5. Ahmed N.K., Gaddis R.R., Tennant K.D., and Lacz J.P. Biological and thrombolytic properties of fibrolase a new fibrinolytic protease from snake venom. Haemostasis 20 (1990) 334-340
6. Toombs C.F. Alfimeprase: pharmacology of a novel fibrinolytic metalloproteinase for thrombolysis. Haemostasis 31 (2001) 141-147
7. C.F. Toombs, A.A. Sasahara, J. Loscalzo, D. Marcel, New Therapeutic Agents in Thrombosis and Thrombolysis, ISBN: (0-8247-0795-8), New York, 2002, pp. 1-720.
8. Deitcher S.R., and Jaff M.R. Pharmacologic and clinical characteristics of thrombolytic agents. Rev. Cardiovasc. Med. 3 (2003) S25-S33
9. Deitcher S.R., and Toombs C.F. Non-clinical and clinical characterization of a novel acting thrombolytic: Alfimeprase. Pathophysiol. Haemost. Thromb. 34 (2005) 215-220
10. Ouriel K., Jacob C., Weaver F.A., Dardik H., Akers D., Blebea J., Gruneiro L., Toombs C.F., Wang-Clow F., Mohler M., Pena L., Wan C.Y., and Deitcher S.R. A phase I trial of Alfimeprase for peripheral arterial thrombolysis. J. Vasc. Interv. Radiol. 16 (2005) 1075-1083
11. Jackson M.R., and Clagett G.P. Antithrombotic therapy in peripheral arterial occlusive disease. Chest 119 (2001) 283-299
12. Moll S., Kenyon P., Bertoli L., Maio J.D., Homesley H., and Deitcher S.R. Phase II trial of Alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devices. J. Clin. Oncol. 24 (2006) 3056-3060
13. Deitcher S.R., Moll S., Homesley H., et al. Safety and efficiency of Alfimeprase for restoring function in occluded central venous catheters: interim results of a phase 2, multicenter, randomized, double-blind study (NuCath). J. Blood (ASH Annual Meeting Abstracts) 104 (2004) 1768
14. Loayza S.L., Trikha M., Markland F.S., Riquelmeb P., and Kuob J. Resolution of isoforms of natural and recombinant fibrolase, the fibrinolytic enzyme from Agkistrodon contortrix contortrix snake venom, and comparison of their EDTA sensitivities. J. Chromatogr. 662 (1994) 227-243
15. Zhang S.T., Shi J., Zhao J., Qi Y.F., and Guo A.G. Expression of soluble and functional snake venom fibrinolytic enzyme fibrolase Via the co-expression of DsbC in Escherichia coli. Protein Peptide Lett. 13 (2006) 559-563
16. Zhang S.T., Zhou Y.S., Lai X.H., Bao X.F., and Guo A.G. Soluble expression and purification of snake venoms: fihrino(geno)lytic emzyme Alfimeprase in E.coli. Chin. Biotechnol. 26 (2006) 31-36
17. 25-0106, pPIC9K: a Pichia vector for multicopy integration and secreted expression, Catalog No. V175-20, www.invitrogen.com, pp.1-34.
18. Wu S.X., and Letchworth G.J. High efficiency transformation by electroporation of Pichia pastoris pretreated with lithium acetate and dithiothreitol. BioTechniques 36 (2004) 152-154
19. Ju H., Liang D.C., Guo G., and Zhang J.Y. Comparison of four methods to prepare Pichia genomic DNA for PCR. J. Tianjin Med. 31 (2003) 270-272
20. Astrup T. The fibrin p late method for estimating fibrinolytic activity. Arch. Biochem. Biophys. 40 (1952) 346
21. Toombs C.F. New directions in thrombolytic therapy. J. Curr. Opin. Pharmacol. 1 (2001) 164-168
22. Hong T.T., Huang J.B., and Benedict R. Effect of thrombolysis on myocardial injury recombinant tissue plasminogen activator vs Alfimeprase. Am. J. Physiol. Heart Circ. Physiol. Am. Physiol. Soc. (2005) 1-38
23. Patrick S.M., Fazenda M.L., McNeil B., and Harvey L.M. Heterologous protein production using the Pichia pastoris expression system. Yeast 22 (2005) 249-270
24. Cregg J.M., Svedvick T., and Raschke W.C. Recent advances in the expression of foreign genes in Pichia pastoris. Biotech. 11 (1993) 905-910
25. Cereghino J.L., and Cregg J.M. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol. Rev. 24 (2000) 45-66
26. Romanos M. Advances in the use of Pichia pastoris for high-level gene expression. Biotech. 6 (1995) 527-533
27. Sreekrishna K., Brankamp R.G., Kropp K.E., Blankenship D.T., Tsay J.T., Smith P.L., Wierschke J.D., Subramaniam A., and Birkenberger L.A. Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris. Gene 190 (1997) 55-62
28. Cereghino G.L., Cereghino J.L., Ilgen C., and Cregg J.M. Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Biotech. 13 (2002) 329-332
29. Rogelj B., Trukelj B.S., Bosch D., and Jongsma M.A. Expression, purification and characterization of Equistatin in Pichia pastoris. Protein Express Purif. 19 (2000) 329-334